PRINCIPIA BIOPHARMA

Serial Number 88709261
606

Registration Progress

Application Filed
Nov 27, 2019
Under Examination
Dec 22, 2020
Approved for Publication
Oct 27, 2020
Published for Opposition
Oct 27, 2020
Registered

Trademark Image

PRINCIPIA BIOPHARMA

Basic Information

Serial Number
88709261
Filing Date
November 27, 2019
Published for Opposition
October 27, 2020
Abandonment Date
January 22, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 22, 2024
Classes
005

Rights Holder

Principia Biopharma Inc.

03
Address
55 Corporate Drive
Bridgewater, NJ 08807

Ownership History

Principia Biopharma Inc.

Original Applicant
03
South San Francisco, CA

Principia Biopharma Inc.

Owner at Publication
03
Bridgewater, NJ

Legal Representation

Attorney
Karen Lim

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

43 events
Date Code Type Description Documents
Jan 22, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 22, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 13, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 12, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 9, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 1, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 1, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 23, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 21, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 21, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 21, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 21, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 19, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 19, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
May 19, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 28, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jan 28, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 28, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 28, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 28, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 28, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 11, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 9, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 9, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 11, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 9, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 9, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 22, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 27, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 27, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 7, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 21, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 12, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 11, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 11, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 11, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 11, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 11, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 2, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 5, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 30, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of immune-mediated diseases and disorders

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOPHARMA"